Health Catalyst Capital II, L.P. — Form D/A
Health Catalyst Capital II, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2020-05-29. The offering totals $275.0M, of which $50.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-05-29
- Form: D/A
- Accession: 0001012975-20-000511
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $275.0M
- Amount sold: $50.8M
- Remaining: $224.2M
- Minimum investment: $50K
- Investors: 12
- Date of first sale: 2019-06-25
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-340653
Issuer
- Name: Health Catalyst Capital II, L.P.
- CIK: 0001777452
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 515 MADISON AVENUE, SUITE 2701, NEW YORK, NY, 10022
- Phone: 212-752-2226
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| N/A Health Catalyst Associates II, LLC | Director | New York, NY |
| Charles Boorady | Executive Officer | Brentwood, TN |
| Daniel Ross | Executive Officer | Provo, UT |
Other filings by this issuer (1)
More